-
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes
13 Dec 2024 16:28 GMT
… to import Afrezza from US’ MannKind Corporation.
A rapid acting insulin … in the past -- from Pfizer (Exubera) and Sanofi ( Afrezza) – only … be discontinued, or returned (to MannKind), respectively . Industry insiders explain, that …
-
MannKind Corp (MNKD) CEO Michael Castagna on Q2 2022 Results - Earnings Call Transcript
10 Aug 2022 02:17 GMT
… , and welcome to the MannKind Corporation's Second … available for playback on the MannKind Corporation website shortly after … presentation. Joining us today from MannKind are Chief Executive Officer, … with when it was at Pfizer. And so that animal …
-
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
17 May 2022 15:27 GMT
… authorize a booster shot of Pfizer Inc PFE/BioNTech SE … 1 and type 2 diabetes.
MannKind Corporation MNKD has agreed to … acquisition of V-Go allows MannKind to expand its portfolio and …
-
Global Pulmonary Drugs Market (2021 to 2027) - Featuring AstraZeneca, Grifols and Pfizer Among Others - ResearchAndMarkets.com
27 Jan 2022 17:14 GMT
… .A.
Merck & Co., Inc.
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sumitomo … ., Ltd.
Teva Pharmaceutical Industries Ltd.,
MannKind Corporation
Gilbert technologies,
Philips Respironics …
-
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions
04 Aug 2021 11:51 GMT
… product.
NRx Pharmaceuticals Partners with MannKind Corporation to Further Develop Inhalable … , J&J, Lilly, Novartis, Pfizer, and the US FDA. NRx … States National Security Advisor.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses …
-
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
25 Feb 2021 16:23 GMT
… Krystal Biotech Inc (NASDAQ: KRYS)
MannKind Corporation (NASDAQ: MNKD) (reacted … Booster Dose, Variant-Specific Vaccine
Pfizer Inc. (NYSE: PFE) … third dose of the Pfizer-BioNTech COVID-19 vaccine … potential future strain changes, Pfizer and BioNTech said they …
-
Homology Medicines: $60 Million Pfizer Equity-Investment, 4 Encouraging Candidates, And Competent Management
22 Dec 2020 17:17 GMT
… inked two fresh partnerships with Pfizer covering phenylketonuria ("PKU… & partnerships (expanded)
Graphic Source: MannKind Corporation Homology Medicines has developed … encouraging given the Novartis and Pfizer partnerships will aid developmental …
-
Neuropeptide Y Receptor Market 2020 Precise Outlook - Gila Therapeutics, Novo Nordisk, XL-protein, Lilly Eli, Novartis, Pfizer, Merck & Co, Mannkind
26 Aug 2020 11:28 GMT
… : LLY), Novartis, Pfizer (NYSE: PFE), Merck & Co, Mannkind, Gilead Sciences, Genentech …
-
MannKind Corporation (MNKD) presents at H.C. Wainwright 21st Annual Global Investment Conference (Transcript)
09 Sep 2019 21:27 GMT
… is Michael Castagna, CEO of MannKind Corporation.
Michael Castagna
Good morning … the product back here to MannKind about three years ago.
…
So those of you knew MannKind, it's basically … our development program, and Pfizer just recently published you know …
-
MannKind Corporation (MNKD) CEO Michael Castagna on Q2 2019 Results - Earnings Call Transcript
08 Aug 2019 05:35 GMT
…
Operator
Welcome to the MannKind Corporation Second Quarter 2019 … for playback on the MannKind Corporation website shortly after … .
Joining us today from MannKind are Chief Executive Officer, … studied historically and fortunately, Pfizer just published a data …
About
© 1995-2024